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INTRODUCTION
Amyloidosis is a connective tissue disease characterized by
the deposition of insoluble, fibrous amyloid proteins, primar-
ily in the extracellular space of organ tissues (1). Although
median nerve compression, or carpal tunnel syndrome, is a
frequent finding of AL amyloidosis, femoral nerve compres-
sion caused by hypertrophic amyloid myopathy has not been
previously described (2).
We report a case of a patient with AL amyloidosis who
developed bilateral lower extremity weakness in association
with femoral nerve compression due to iliopsoas pseudo-
hypertrophy.
CASE REPORT
A 54-yr-old man visited our clinic because of lower extremi-
ty weakness and polyarthritis involving the shoulders, wrists,
and hands. He had been in good health until 2 months prior
to visiting our clinic, when he began to experience anorexia
and fatigue. At that time, he was diagnosed at a local hospital
as having end stage renal disease (ESRD) of unknown etiology
and was started on regular hemodialysis. About a week after
initiating hemodialysis, he had pain and swelling in both
shoulders, wrists and metacarpophalangeal (MCP) joints, fol-
lowed by progressive bilateral lower extremity weakness,
which caused him to visit our clinic. He also began to have a
tingling sensation in both hands.
On admission, his blood pressure was 135/88 mmHg, heart
rate 94/min, respiration rate 20/min, and body temperature
36.2℃. A physical examination showed severe swelling in
both hands and feet, and tenderness at wrists, MCP joints,
and shoulders. Bilateral shoulder pads were also present. Se-
vere, isolated bilateral knee extensor weakness (muscle streng-
th grade I) was detected, with relatively preserved strength of
knee flexors and of hip and ankle flexors and extensors (grade
IV to V). A decreased sensation in medial thighs was noted.
Diffuse, firm swelling of bilateral inguinal area was detected.
Deep tendon reflex in both knees was reduced, as was grasp-
ing power in both hands. Laboratory data showed anemia
(hemoglobin of 8.3 g/dL), azotemia (creatinine of 6.7 mg/dL),
and elevated ionized calcium level of 1.55 mEq (normal 1.05-
1.35). The serum total protein and albumin levels were 5.7
g/dL (normal 6.0-8.0) and 3.4 g/dL (normal 3.3-5.2), respec-
tively. The serum creatine kinase level was 117 IU/L (normal
20-270), lactate dehydrogenase, 287 IU/L (normal 100-225),
and beta 2-microglobulin, 52.9 mg/L (normal 1-3). Erythro-
cyte sedimentation rate of 76 mm/hr (normal 0-10) and C-
reactive protein level of 2.0 mg/dL (normal 0-0.5) were mea-
sured. Urinalysis with microscopy showed three positive
amount of albumin excretion and normal sediment findings.
Serum anti-nuclear antibody and rheumatoid factor were
negative. An electrocardiogram showed normal sinus rhythm
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A Case of Femoral Compressive Neuropathy in AL Amyloidosis
We describe a case of a 54-yr-old AL amyloidosis patient who developed femoral
compressive neuropathy due to iliopsoas pseudohypertrophy. The patient, who pre-
sented with end stage renal disease, was referred to our clinic because of lower
extremity weakness and polyarthritis. Finally, he was diagnosed as having kappa-
AL amyloidosis, complicated by femoral compressive neuropathy, hypertrophic amy-
loid myopathy, amyloid arthropathy, carpal tunnel syndrome, and end stage renal dis-
ease. Femoral compressive neuropathy has never been reported in association with
amyloid induced iliopsoas hypertrophic myopathy. This report expands the clinical
spectrum of AL amyloidosis.
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without any particular abnormalities. Simple radiographic
films of the shoulders, hands, feet and the whole spine failed
to show any specific bony abnormalities, but did show diffuse
systemic osteopenia and soft tissue swelling in both hands and
feet. Ultrasonography revealed bilaterally contracted kidneys.
Amyloidosis was confirmed by the shoulder pad biopsy,
which showed an apple green birefringence under polarized
light when stained with Congo red and the characteristic non-
branching fibrillar structure of amyloid by electron micro-
scopy. Immunofluorescent staining (IF) for kappa light chain
was strongly positive (Fig. 1). Negative M spike in serum/
urine protein electrophoresis, abnormal kappa chain arc in
serum/urine immunoelectrophoresis, and bone marrow plas-
macytosis (12.9%) suggested kappa-AL amyloidosis associ-
ated with plasma cell dyscrasia. There was no evidence of
muscular amyloid deposition in the quadriceps biopsy, ruling
out amyloid deposition in quadriceps muscle as the cause of
knee extensor weakness. Subsequent bilateral femoral nerve
conduction study (NCS) and vastus lateralis/medialis electro-
myography showed typical neuropathic findings (decreased
compound muscle action potential (CMAP) amplitude, abnor-
mal spontaneous activity, discrete interference pattern). Median
NCS revealed no formation of CMAPs and sensory nerve
action potentials, in contrast with intact ulnar NCS. These
findings indicated bilateral femoral and median nerve palsies
as the causes of the weakness in knee extensors and of the
grasping difficulty in hands. To identify the culprit lesions
causing nerve palsies and to evaluate the painful shoulder jo-
ints, we obtained magnetic resonance images (MRI) of the
wrists, pelvis and shoulders. The MRI findings showed bilat-
eral wrist joint fluid accumulation, median nerve compaction
in a swollen carpal tunnel, intrinsic hand muscle swelling,
marked iliopsoas hypertrophy, and prominent subdeltoid
bursa thickening. Iliopsoas muscle showed heterogeneous inten-
sity in both T1 and T2 weighted images with irregular gado-
linium enhancement in T1 weighted images (Fig. 2). The
neurovascular bundle containing the femoral nerve was medi-
ally adjacent to the iliopsoas muscle, which seemed to com-
press the bundle. We were unable to find subcutaneous fat
reticulation at the mid-thigh level, previously reported in the
few cases of MRI findings in amyloid myopathy.
A month after admission, we performed bilateral carpal
Fig. 1. Immunofluorescent staining of the shoulder pad biopsy
shows diffuse, strong deposits of kappa light chains (×200).
Fig. 2. Pelvis MRI. Enhanced T1-weighted (A) and T2-weighted (B) images, demonstrating pseudohypertrophied iliopsoas muscles (arrow
heads) compressing femoral nerves (arrows).
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tunnel release and psoas muscle excision, to decompress the
nerves. During the operation, tight adhesion was found be-
tween the femoral nerves and the psoas muscles. All surgical
specimens gained from carpal tunnel release and psoas muscle
excision showed an apple green color under polarized light
with Congo red staining and showed the same characteristic
fibrillar structure of amyloid by electron microscopy, as was
found in the shoulder pad biopsy. In muscle specimens, de-
posits were primarily distributed in the perimysium, endomy-
sium and perivascular space with scanty inflammatory cells
(Fig. 3). Variable-sized muscle fibers were frequently separated
by a thickened interstitium. About three weeks after the oper-
ation, he could grasp with both hands and his knee extensor
strength improved gradually to grade III. We planned to try
chemotherapy consisting of dexamethasone and cyclophos-
phamide after the wound healed.
A month after the operation, he began to suffer profuse diar-
rhea due to intestinal amyloidosis. His diarrhea was refractory
despite one cycle of chemotherapy. Subsequently, serious mal-
nutrition ensued. He died of severe cachexia and combined
infection six weeks after the chemotherapy.
DISCUSSION
The involvement of skeletal muscles by AL amyloidosis can
be divided into two phenotypes. One is characterized by prox-
imal muscle atrophy and presents with inflammatory myosi-
tis-like features (3, 4). The other is characterized by muscle
pseudohypertrophy, macroglossia, or palpable intramuscular
masses without inflammatory infiltration or elevated muscle
enzymes (5, 6). The present case belongs more to the latter
form. However, it is distinctive in that muscle weakness was
associated with compressive neuropathy rather than amyloid
myopathy itself.
Amyloid arthropathy in multiple myeloma is known to be
rare and presents in the form of shoulder hypertrophic arthro-
pathy or of rheumatoid arthritis-like peripheral arthritis (7).
The polyarthritis in this case, resulting from amyloid depo-
sition in the periarticular tissues, showed both forms of arthro-
pathy by involving both shoulders, wrists, and MCP joints.
Although the marked periarticular amyloid deposition seen
in this case, together with his ESRD status, reminded us of
dialysis associated amyloidosis, this seemed to be unlikely
because the duration of dialysis (< 2 months) was too short
for this type of amyloidosis and because clinically relevant vis-
ceral involvement, which manifested as intestinal amyloido-
sis in this patient, is known to be rare in dialysis associated
amyloidosis, and to be largely confined to long term patients
with more than 15 yr of dialysis (8). The positive IF for kappa
light chain in the shoulder pad biopsy confirmed this spec-
ulation.
Carpal tunnel syndrome seen in this case, is not only a fre-
quent finding of AL amyloidosis, but also one of the most
common features of hereditary amyloidosis which is charac-
terized by a family history (autosomal dominant), and in most
cases, sensorimotor polyneuropathy (2). The diagnosis of
hereditary amyloidosis is often missed even though different
forms of hereditary systemic amyloidoses has been found in
as many as 9.7% of patients who were initially classified as
having AL amyloidosis and though the prognosis can be im-
proved with liver transplantation (9, 10). A Korean case of
Fig. 3. Endomysial and perimysial deposition of amyloid in the iliopsoas muscle. Congo red with light microscopy (A) and with polarizing
microscopy (B) (×100).
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hereditary amyloidosis, as a form of familial amyloid polyneu-
ropathy, has been reported (11). In our case, however, the defi-
nite documentation of plasma cell dyscrasia, no clinical pen-
etrance of polyneuropathy in a family history as well as in his
manifestations, and finally, the positive IF demonstrating
kappa light chains as a precursor protein made it possible to
exclude hereditary amyloidosis as the underlying process of
the disease.
In this case, light chain deposition disease might have been
co-present with AL amyloidosis, and played a role in renal
failure, because strong and diffuse immunofluorescence, which
is unusual in AL amyloiosis, is a finding consistent with light
chain deposition disease, as is kappa rather than lamda light
chain involvement (12).
In summary, we present a rare case of AL amyloidosis with
femoral nerve compressive neuropathy, hypertrophic amyloid
myopathy and amyloid arthropathy. It should be emphasized
that various musculoskeletal involvements including polyar-
thritis and proximal muscle weakness constitute elusive man-
ifestations of amyloidosis and that not only amyloid myo-
pathy but also compressive neuropathy should be included
in the differential diagnosis of muscle weakness in amyloido-
sis, especially when muscular hypertrophy is present.
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